Tumor-derived IL-6 phosphorylates STAT3 and stimulates two noncanonical NF-kB subunits, p52 and RelB to form a dimer that directly binds to the promoter of IDO1, then drives the expression of IDO1 in MDSCs [61,116]. The gene discussed is IL6; the disease is neoplasm.